PHILADELPHIA--(BUSINESS WIRE)--May 1, 2006--Galleon Pharmaceuticals, an early-stage company focused on developing a revolutionary class of medicine for sleep apnea and other breathing control diseases, was awarded the SR One Biotech Company of the Year at the 8th Annual Angel Venture Fair. Galleon is pioneering the development of a new therapeutic area that may benefit millions with sleep apnea. Recent discoveries into how the brain controls breathing are enabling this new class of medicines for use in common conditions such as sleep apnea, heart failure, stroke, and chronic obstructive pulmonary disease (COPD).
